Tibolone
Alternative Names: Boltin; KB 889; Livial; Liviella; Livifem; ORG OD 14; Paraclim; XyvionLatest Information Update: 05 Nov 2023
Price :
$50 *
At a glance
- Originator Nourypharma; Organon
- Developer Organon
- Class Hormonal replacements; Norpregnenes; Osteoporosis therapies
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Menopausal syndrome; Postmenopausal osteoporosis
Most Recent Events
- 25 Jan 2018 Tibolone licensed to Grunenthal for commercialisation and distribution in Brazil, Central America, Colombia, Mexico and Peru
- 05 Feb 2014 MSD Korea and Hanmi Pharmaceutical agree to co-promote tibolone in South Korea for Menopausal syndrome
- 19 Nov 2007 Organon has been acquired and merged into Schering-Plough